Suppr超能文献

分光光度法测定格列美脲和盐酸吡格列酮混合物及其在药物制剂中的应用。

Spectrophotometric methods for determination of glimepiride and pioglitazone hydrochloride mixture and application in their pharmaceutical formulation.

机构信息

Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr el Aini Street, 11562 Cairo, Egypt.

National Organization for Drug Control & Research (NODCAR), Egyptian Drug Authority, Giza 12311, Egypt.

出版信息

Spectrochim Acta A Mol Biomol Spectrosc. 2022 Apr 5;270:120745. doi: 10.1016/j.saa.2021.120745. Epub 2021 Dec 14.

Abstract

Simple, accurate, and precise four spectrophotometric methods were developed and validated for simultaneous determination of glimepiride and pioglitazone hydrochloride in their pharmaceutical formulation. The first spectrophotometric method was the dual-wavelength which determined glimepiride at 219.0 and 228.0 nm and pioglitazone hydrochloride at 268.0 nm. The second one is the first derivative of ratio spectra (DD1) spectrophotometry in which the peak amplitudes were used at 238.0 nm and 268.0 nm for glimepiride and pioglitazone hydrochloride, respectively. The third method is ratio subtraction in which glimepiride was determined at 228.0 nm in the presence of pioglitazone hydrochloride which was determined by extended ratio subtraction at 268.0 nm. The fourth method was the ratio difference to determine glimepiride and pioglitazone hydrochloride. Beer's law was confirmed in the concentration range 2.50-15.00 µg mL-1, and 10.00-50.00 µg mL-1 for glimepiride and pioglitazone respectively for the four methods. The proposed methods were used to determine both drugs in their pure powdered form with mean percentage recoveries of 99.91 ± 1.117% for glimepiride and 99.76 ± 0.911% for pioglitazone hydrochloride in method (A). In method (B), the mean percentage recoveries were 100.12 ± 0.89% for glimepiride and 100.02 ± 1.06% for pioglitazone hydrochloride. In method (C) glimepiride was 100.01 ± 0.592% and 99.85 ± 0.845% for pioglitazone hydrochloride by extended ratio subtraction. And finally, in method (D) the mean percentage recoveries were 100.66 ± 0.670% for glimepiride and 99.92 ± 0.988% for pioglitazone hydrochloride. The developed methods were successfully applied for the determination of glimepiride and pioglitazone hydrochloride in pure powder and dosage form. The suggested methods were also used to determine both compounds in laboratory-prepared mixtures. The accuracy, precision, and linearity ranges of the developed methods were determined. The results obtained were compared statistically with the official method, and there was no significant difference between the proposed methods and the official method for accuracy and precision.

摘要

建立并验证了四种简单、准确且精密的分光光度法,用于同时测定其药物制剂中格列美脲和吡格列酮盐酸盐的含量。第一种分光光度法是双波长法,在 219.0nm 和 228.0nm 处测定格列美脲,在 268.0nm 处测定吡格列酮盐酸盐。第二种方法是导数比光谱(DD1)分光光度法,其中使用 238.0nm 和 268.0nm 处的峰振幅分别测定格列美脲和吡格列酮盐酸盐。第三种方法是差示比减法,在存在吡格列酮盐酸盐的情况下,于 228.0nm 处测定格列美脲,吡格列酮盐酸盐则通过扩展差示比减法在 268.0nm 处测定。第四种方法是比值差减法,用于同时测定格列美脲和吡格列酮盐酸盐。四种方法的线性范围均为 2.50-15.00μg/mL 和 10.00-50.00μg/mL 之间,分别用于测定格列美脲和吡格列酮盐酸盐。该方法已用于纯粉末形式的两种药物的测定,在方法 A 中,格列美脲的平均回收率为 99.91±1.117%,吡格列酮盐酸盐的平均回收率为 99.76±0.911%。在方法 B 中,格列美脲的平均回收率为 100.12±0.89%,吡格列酮盐酸盐的平均回收率为 100.02±1.06%。在方法 C 中,通过扩展差示比减法,格列美脲的回收率为 100.01±0.592%,吡格列酮盐酸盐的回收率为 99.85±0.845%。最后,在方法 D 中,格列美脲的平均回收率为 100.66±0.670%,吡格列酮盐酸盐的平均回收率为 99.92±0.988%。所建立的方法成功地用于纯粉和制剂中格列美脲和吡格列酮盐酸盐的测定。所提出的方法也用于测定实验室制备混合物中的两种化合物。对所建立方法的准确性、精密度和线性范围进行了评价。所得结果与官方方法进行了统计学比较,在准确性和精密度方面,所提出的方法与官方方法没有显著差异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验